Birinapant
- Generic Name
- Birinapant
- Drug Type
- Small Molecule
- Chemical Formula
- C42H56F2N8O6
- CAS Number
- 1260251-31-7
- Unique Ingredient Identifier
- 6O4Z07B57R
- Background
Birinapant has been investigated for the treatment of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath